TriangleValemetostat (NCT06807632)
Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for extensive stage small cell lung cancer, as maintenance therapy, in adults.
The idea: test valemetostat together with atezolizumab. The researchers will test different doses of valemetostat to find the highest dose that causes few or mild side effects. Then they test that dose in a new group of patients to learn more about safety. Daiichi Sankyo is listed as a collaborator.
This phase 1 study plans 24 patients. At Memorial Sloan Kettering Cancer Center in New York, Jessica Ross leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.